Background: Assessment of early response to treatment is crucial for the management of community-acquired pneumonia (CAP).
Objective: To describe the predictors and the outcomes of early clinical stability.
Methods: We did a secondary analysis of a multicentre randomized controlled trial on CAP treatment in which 580 patients hospitalized for moderately severe CAP were included.